Drug Trial Radar · NCT04400838
Investigating a Vaccine Against COVID-19
Last checked: Nov 19, 2026Latest source record: Sep 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10,811
Actual
Start
May 28, 2020
Primary completion
Feb 5, 2025
Study completion Feb 5, 2025
Sponsor
- Lead sponsor
- University of OxfordAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 26, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Single (participant)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in healthy UK volunteers.
Conditions
- Coronavirus
Interventions
ChAdOx1 nCoV-19 (Abs 260)Biological
A single dose of 5x10\^10vp of ChAdOx1 nCoV-19 measured by spectrophotometry at Abs260
MenACWY vaccineBiological
Standard single dose of MenACWY vaccine
ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR) boostBiological
A single dose of 5x10\^10vp of ChAdOx1 nCoV-19 measured by spectrophotometry at Abs260 and 2.2x10\^10vp ChAdOx1 nCoV-19 boost measured by qPCR 4-6 weeks later
Two dose MenACWY vaccineBiological
Two standard doses of MenACWY vaccine 4-6 weeks apart
ChAdOx1 nCoV-19 (qPCR)Biological
A single dose of 5x10\^10vp of ChAdOx1 nCoV-19 measured by qPCR
ChAdOx1 nCoV-19 0.5mL prime plus boostBiological
Two dose ChAdOx1 nCoV-19 0.5mL (3.5 - 6.5 × 10\^10 vp Abs 260)
Two dose MenACWY vaccine min. 4 weeks apartBiological
Two standard doses of MenACWY vaccine minimum 4 weeks apart
Two dose ChAdOx1 nCoV-19/Covishield 0.5mLBiological
Two dose ChAdOx1 nCoV-19 0.5mL (Covishield 0.9 x 10\^11 vp/mL), 4-6 weeks apart
Two dose ChAdOx1 nCoV-19/Covishield 0.25mL & 0.5mLBiological
Two dose ChAdOx1 nCoV-19 (Covishield 0.9 x 10\^11 vp/mL), 0.25mL prime and 0.5mL boost 4-6 weeks apart
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assess the efficacy of the candidate ChAdOx1 nCoV-19 against COVID-19 in adults aged 18 years and older.Time frame: Study duration (12 months from last vaccination)
- Assess the safety of the candidate vaccine ChAdOx1 nCoV-19 in adultsTime frame: Study duration (12 months from last vaccination)
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
University Hospitals Bristol and Weston NHS Foundation Trust
Bristol, United Kingdom
North Bristol NHS Trust
Bristol, United Kingdom
NIHR Cambridge Clinical Research Facility
Cambridge, United Kingdom
NHS Lothian, Western General Hospital
Edinburgh, United Kingdom
Glasgow University and NHS Greater Glasgow & Clyde, New Lister Building, Glasgow Royal Infirmary & Queen Elizabeth University Hospital
Glasgow, United Kingdom
Liverpool School of Tropical Medicine (LSTM), Accelerator Research Clinic. Clinical Sciences Accelerator
Liverpool, United Kingdom
London North West University Healthcare Trust (LNWUH), Northwick Park Hospital
London, United Kingdom
University College London Hospitals NHS Foundation Trust
London, United Kingdom
Guy's and St Thomas' NHS Foundation Trust, Department of Infection, St Thomas Hospital
London, United Kingdom
Imperial College Healthcare NHS Trust
London, United Kingdom
The Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
Public Health Wales
Newport, United Kingdom
University of Nottingham Health Service, Cripps Health Centre, University Park
Nottingham, United Kingdom
CCVTM, University of Oxford, Churchill Hospital
Oxford, United Kingdom
John Radcliffe Hospital
Oxford, United Kingdom
Sheffield Teaching Hospitals, Royal Hallamshire Hospital
Sheffield, United Kingdom
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, United Kingdom
Castle Hill Hospital
Cottingham, Hull, United Kingdom
St Georges University Hospital NHS Foundation Trust
London, Tooting, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.